Enjoy complimentary customisation on priority with our Enterprise License!
The atherosclerosis therapeutics market size is forecast to increase by USD 2.66 billion at a CAGR of 4.5% between 2023 and 2028. The market is witnessing significant growth due to the rising prevalence of cardiovascular diseases, particularly in the geriatric population and health-conscious consumers. The market is driven by the identification of new targets for atherosclerosis treatment and the development of more effective therapeutics to address the side effects associated with existing medications, such as antiplatelet medications, cholesterol-lowering medications, beta blocker medications, and ACE inhibitor medications. Clinical trials are ongoing to evaluate the efficacy and safety of new therapeutic approaches. Extremities, including the legs and arms, are increasingly becoming a focus for atherosclerosis treatment due to the high incidence of peripheral arterial disease. The market is also influenced by factors such as medical tourism and e-commerce, which offer cost-effective treatment options to consumers. Consumption of carbohydrate-based foods and sedentary lifestyles further contribute to the market growth. It is essential for market players to stay updated on these trends and challenges to remain competitive in the market.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.